BACKGROUND: Osteoclast activation plays an essential role in the development of bone metastasis (BM). Integrin alpha(v)beta3 mediates the attachment of osteoclasts to bone matrix, and it is overexpressed in bone-residing breast cancer cells. We studied BM from breast cancer in relation to its Integrin alpha(v)beta3 expression. MATERIALS AND METHODS: Integrin alpha(v)beta3 expression in 4 human breast cancer cell lines (MDA-MB-231, MDA-MB-435, MKL-4 and T-47D) was determined by immunohistochemistry, flow cytometry and reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: Integrin alpha(v)beta3 was expressed in MDA-MB-231 and MDA-MB-435, but not in MKL-4 or T-47D, using both immunohistochemistry and flow cytometry. By RT-PCR, positive bands for both alpha(v) and beta3 subunits were identified in MDA-MB-231 and 435, while only the alpha(v) subunit mRNA was present in MKL-4 and T-47D. BM was common in vivo following inoculation with MDA-MB-231 or 435, but not with MKL-4. CONCLUSION: Integrin alpha(v)beta3 expression appears to play a key role in the development of BM from breast cancer.
BACKGROUND: Osteoclast activation plays an essential role in the development of bone metastasis (BM). Integrin alpha(v)beta3 mediates the attachment of osteoclasts to bone matrix, and it is overexpressed in bone-residing breast cancer cells. We studied BM from breast cancer in relation to its Integrin alpha(v)beta3 expression. MATERIALS AND METHODS:Integrin alpha(v)beta3 expression in 4 humanbreast cancer cell lines (MDA-MB-231, MDA-MB-435, MKL-4 and T-47D) was determined by immunohistochemistry, flow cytometry and reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS:Integrin alpha(v)beta3 was expressed in MDA-MB-231 and MDA-MB-435, but not in MKL-4 or T-47D, using both immunohistochemistry and flow cytometry. By RT-PCR, positive bands for both alpha(v) and beta3 subunits were identified in MDA-MB-231 and 435, while only the alpha(v) subunit mRNA was present in MKL-4 and T-47D. BM was common in vivo following inoculation with MDA-MB-231 or 435, but not with MKL-4. CONCLUSION:Integrin alpha(v)beta3 expression appears to play a key role in the development of BM from breast cancer.
Authors: Jing Sun; Zhao-Gang Teng; Ying Tian; Jian-Dong Wang; Yang Guo; Dong-Hyun Kim; Andrew C Larson; Guang-Ming Lu Journal: Int J Clin Exp Med Date: 2014-12-15
Authors: Jay S Desgrosellier; Jacqueline Lesperance; Laetitia Seguin; Maricel Gozo; Shumei Kato; Aleksandra Franovic; Mayra Yebra; Sanford J Shattil; David A Cheresh Journal: Dev Cell Date: 2014-08-11 Impact factor: 12.270
Authors: Dan Shan; Jason Li; Ping Cai; Preethy Prasad; Franky Liu; Andrew Michael Rauth; Xiao Yu Wu Journal: Drug Deliv Transl Res Date: 2015-02 Impact factor: 4.617
Authors: Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin Journal: Adv Funct Mater Date: 2020-03-03 Impact factor: 18.808
Authors: Laetitia Seguin; Shumei Kato; Aleksandra Franovic; M Fernanda Camargo; Jacqueline Lesperance; Kathryn C Elliott; Mayra Yebra; Ainhoa Mielgo; Andrew M Lowy; Hatim Husain; Tina Cascone; Lixia Diao; Jing Wang; Ignacio I Wistuba; John V Heymach; Scott M Lippman; Jay S Desgrosellier; Sudarshan Anand; Sara M Weis; David A Cheresh Journal: Nat Cell Biol Date: 2014-04-20 Impact factor: 28.824
Authors: Jay S Desgrosellier; Leo A Barnes; David J Shields; Miller Huang; Steven K Lau; Nicolas Prévost; David Tarin; Sanford J Shattil; David A Cheresh Journal: Nat Med Date: 2009-09-06 Impact factor: 53.440